Cytarabine and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytarabine (cytarabine) and Ezetimibe (ezetimibe). Common drug interactions include pruritus among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Cytarabine and Ezetimibe. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

On Jul, 17, 2026

25 people who take Cytarabine and Ezetimibe together, and have interactions are studied.

Cytarabine and Ezetimibe drug interactions.

What are the common drug interactions of Cytarabine and Ezetimibe, by gender? *:

female:

Pruritus (severe itching of the skin)
Purpura (purplish discoloration of the skin)
Rash erythematous (redness of the skin)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

male:

Gait disturbance
Aplasia (defective development or congenital absence of an organ or tissue)
Muscular weakness (muscle weakness)
Platelet count decreased
Staphylococcal infection (an infection with staphylococcus bacteria)
Systemic candida (whole body fungal infection)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Infection
Blood bilirubin increased

What are the common drug interactions of Cytarabine and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Thrombocytopenia (decrease of platelets in blood)

60+:

Gait disturbance
Pruritus (severe itching of the skin)
Platelet count decreased
Staphylococcal infection (an infection with staphylococcus bacteria)
Systemic candida (whole body fungal infection)
Febrile neutropenia (fever with reduced white blood cells)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Infection
Rash erythematous (redness of the skin)

What are the existing conditions these people have? *

Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 14 people, 56.00%
High Blood Pressure: 9 people, 36.00%
Dyslipidaemia (abnormal amount of lipids): 8 people, 32.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 28.00%
Neuropathy Peripheral (surface nerve damage): 7 people, 28.00%
Insomnia (sleeplessness): 7 people, 28.00%
Essential Tremor: 7 people, 28.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 24.00%
Diabetes: 2 people, 8.00%
Bone Marrow Conditioning Regimen: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously